Linus Health

Overview
News
Age Tech?
Mental Health Tech?
Product stageSegments
Seed
?
Caregiver and Healthcare Provider Technology Platforms
?

Linus Health offers a plug-and-play solution for the early detection, treatment, and prevention of cognitive health issues using its “DCTclock” FDA-registered technology. The solution is a spin-off from Lahey Hospital & Medical Center and MIT as a medical device for cognitive assessments deployed using built-in sensors and AI-based analysis. The technology allows care professionals to monitor seniors’ brain health remotely outside clinical settings.

In July 2021, the company stated that its technology was proven effective in detecting early signs of Alzheimer’s disease in research conducted by Massachusetts General Hospital. A more in-depth study is to be carried out by the Global Alzheimer’s Platform Foundation.

In March 2024, the company launched its new Digital Trail Making Test Part B, an FDA Class II- listed medical device, and introduced a Hearing Screener system to its AI-based digital cognitive assessment platform.

In March 2022, the company acquired physical function assessment startup Kinesis Health Technologies which will operate as a subsidiary of Linus Health. Linus Health plans to refine and offer more holistic and proactive health screening services via the acquisition.

In March 2024, the company acquired Aural Analytics , a software provider that evaluates speech to assess cognitive conditions. The acquisition was carried out for an undisclosed sum. Linus planned to harness Aural's technology to enhance its cognitive assessment tests. The acquired assets would enable Linus to expand its operations into the life sciences industry, allowing its technology to be used in pharmaceutical trials and clinical research.

In July 2024, Linus Health acquired Together Senior Health, a brain health company delivering evidence-based solutions for individuals with cognitive decline, for an undisclosed sum. Through the acquisition, Linus aimed to expand its platform's capabilities, combining objective and subjective cognitive assessments with actionable guidance for providers and patients.



HQ location:
210 Bear Hill Road Suite 301 Waltham, MA, 02451 Waltham MA USA
Founded year:
2019
Employees:
51-100
IPO status:
Private
Total funding:
USD 64.9 mn
Last Funding:
USD 55.0 mn (Series B; Jul 2021)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.